Blood Preparation Market (2025 to 2035)

Blood Preparation Market Summary:

The global Blood Preparation market size was valued at approximately USD 51.25 billion in 2025 and is projected to reach USD 97.73 billion by 2035, expanding at a CAGR of 6.67% from 2026 to 2035. Market growth is driven by the rising global burden of trauma, surgical procedures, hematological disorders, and cancer requiring transfusion support, growing maternal health and chronic disease transfusion needs, increasing voluntary blood donation initiatives backed by national health authorities, and the expanding role of plasma-derived medicinal products in treating immune deficiencies and rare diseases. According to the World Health Organization, approximately 120.4 million blood donations are collected globally each year, with significant disparities in access between high-income and low- and middle-income countries.

Blood Preparation Market Revenue Forecast, 2022–2035 (US$ Billion)

Years	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035
Revenue (USD Bn)	42.85	45.18	48.07	51.25	54.62	58.23	62.08	66.2	70.61	75.34	80.38	85.78	91.55	97.73

Key Market Takeaways & Insights

• The United States Blood Preparation market held the largest share of 38.00% of the global market in 2025.
• The Blood Preparation industry in China is expected to grow 32.00% significantly over the forecast period.
• By product type, the Plasma segment held the largest market share of 34.80% in 2025.
• By application, the Trauma & Surgery segment held the largest market share 36.70% in 2025.
• By end use, the Hospitals & Blood Banks segment held the largest market share 48.60% in 2025

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Blood Preparation Market Size: USD 51.25 Billion
• 2032 Blood Preparation Market Size: USD 97.73 billion
• CAGR (2026-2035): 6.67%

Blood Preparation Market Regional Forecast Analysis, 2022–2035 (US$ Billion)

Region	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035
North America	16.71	17.49	18.46	19.48	20.59	21.78	23.05	24.36	25.77	27.27	28.86	30.54	32.31	34.21
Europe	12.43	13.06	13.84	14.71	15.56	16.48	17.45	18.47	19.56	20.72	21.94	23.25	24.63	26.19
Asia Pacific	9.43	10.12	10.96	11.94	13	14.15	15.4	16.75	18.21	19.81	21.54	23.42	25.45	27.56
Latin America	2.57	2.71	2.88	3.08	3.28	3.49	3.72	3.97	4.24	4.52	4.82	5.15	5.49	5.86
Middle East & Africa	1.71	1.81	1.92	2.05	2.18	2.33	2.48	2.65	2.82	3.01	3.22	3.43	3.66	3.91

Clinical Demand & Usage Analysis:

• Rising Incidence of Road Traffic Accidents & Trauma
• Growing Surgical Volumes (Cardiac, Transplant, Oncology)
• Increasing Prevalence of Hematological & Genetic Blood Disorders
• Maternal Health Complications Requiring Transfusion Support

Treatment & Clinical Use Landscape Overview:

• Blood Preparation is a Critical Supportive-Care Resource
• Trauma & Emergency Medicine Use
• Oncology & Hematology Transfusion Support
• Plasma-Derived Medicinal Products (Immunoglobulins, Albumin, Clotting Factors)

Blood Preparation Market Outlook Analysis Conservative, Likely, Optimistic, (US$ Billion), 2025–2035

	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035
Conservative	51.25	53.9	56.7	59.65	62.75	66	69.45	73.05	76.85	80.85	85.05
Likely	51.25	54.62	58.23	62.08	66.2	70.61	75.34	80.38	85.78	91.55	97.73
Optimistic	51.25	55.4	59.95	64.9	70.3	76.15	82.5	89.4	96.9	105	113.9

Market Dynamics:

Market Drivers:

Rising Global Demand for Safe Blood and Blood Components in Trauma, Surgery and Oncology Care

The growing volume of surgical procedures, road traffic trauma, and cancer treatment worldwide is a major driver of the Blood Preparation market. Blood components such as red blood cells, platelets, and plasma are essential supportive-care resources for managing hemorrhage, chemotherapy-induced cytopenias, and complex surgical interventions. The World Health Organization notes that blood and blood components are classified as essential medicines, underscoring the need for adequate, nationally coordinated supply chains. Health authorities and blood transfusion services globally continue to scale up donor recruitment, component separation capacity, and hemovigilance systems to meet rising clinical demand, particularly as ageing populations and the global burden of non-communicable diseases increase reliance on transfusion-dependent care.

Expanding Use of Plasma-Derived Medicinal Products and National Plasma Self-Sufficiency Programmers

Government-led initiatives to expand domestic plasma collection for fractionation into immunoglobulins, albumin, and clotting factor concentrates are significantly contributing to growth in the Blood Preparation market. In the United Kingdom, NHS Blood and Transplant has collected over 250,000 litres of plasma from domestic donors since 2021, with the NHS targeting 25% self-sufficiency in immunoglobulin by the end of 2025 and 80% self-sufficiency in albumin shortly after, reducing reliance on imported plasma medicines. Similar plasma self-sufficiency strategies are being pursued across Europe under the EDQM Blood Guide framework and the EU Substances of Human Origin Regulation (EU) 2024/1938, which strengthens quality and safety standards for blood, plasma, and blood components across member states.

Market Restraint:

Persistent Shortages, Short Shelf Life and Logistical Constraints in Blood Supply Chains

Whole blood and blood components have a limited shelf life (typically 35-42 days for red cells and as little as 5-7 days for platelets), which makes maintaining a stable, geographically distributed supply chain logistically challenging. The WHO Global Database on Blood Safety highlights significant disparities in blood collection rates, with high-income countries collecting a disproportionate share of global donations relative to population, while many low- and middle-income countries face chronic shortages. Seasonal donor shortfalls, cold-chain transport requirements, and the need for rapid, error-free component processing and testing for transfusion-transmissible infections continue to restrain consistent market growth, particularly in resource-constrained healthcare settings.

Stringent Regulatory Compliance and Donor Eligibility Requirements

Blood establishments are subject to extensive regulatory oversight covering donor eligibility, donation suitability, component processing, labelling, and quarantine hold requirements. In the United States, the FDA continues to update blood-related guidance, including 2024-2025 recommendations on hepatitis B surface antigen testing, transfusion-transmitted malaria risk reduction, and buffy-coat component manufacturing, all of which require ongoing validation and compliance investment from blood establishments. Comparable regulatory complexity exists in Europe through the EDQM Blood Guide (22nd edition, 2025) and the incoming EU SoHO Regulation, increasing operational costs and compliance burden, especially for smaller blood centers.

Market Opportunities:

Expansion of Domestic Plasma Fractionation and Voluntary Donation Programmers in Emerging Markets

Growing national investment in voluntary, non-remunerated blood donation infrastructure presents a significant opportunity for the Blood Preparation market. In India, the Ministry of Health and Family Welfare's e-RaktKosh platform and the National Blood Transfusion Council continue to expand real-time blood inventory tracking, donor engagement, and hemovigilance across thousands of blood centers nationwide, supported by WHO India technical collaboration on quality-assured blood services. Comparable programmed across Asia, the Middle East, and Latin America, combined with rising investment in plasma fractionation capacity and component-separation technology, are expected to expand access to safe blood and blood-derived therapeutics and support long-term market growth.

Blood Preparation Market Share Analysis by Segments, 2025 (%)

By Segments	2025
By Product Type	Plasma 34.8%
By Application	Trauma & Surgery 36.7%
By End Use	Hospitals & Trauma Centers 48.6%

Blood Preparation Market Segmentations Analysis:

By Product Type:

Whole Blood, Red Blood Cells (RBCs), Plasma, Platelets, Cryoprecipitate, White Blood Cells, Others

Plasma – Dominating Segment

Held the largest market share due to its broad clinical use in immunoglobulin and albumin production, trauma and burn care, coagulopathy management, and growing national plasma self-sufficiency programmers.

By Application:

Trauma & Surgery, Oncology & Hematology, Anemia & Blood Disorders, Maternal & Neonatal Care, Immune Deficiencies, Others

Trauma & Surgery – Dominating Segment

Accounted for the largest market share due to the high volume of emergency transfusions required for road traffic accidents, internal hemorrhage, and major surgical procedures.

By End Use: Hospitals & Trauma Centers, Blood Banks & Transfusion Centers, Diagnostic & Clinical Laboratories, Academic & Research Institutes, Plasma Fractionation Companies

Hospitals & Trauma Centers – Dominating Segment

Market Regional Insights:

Blood Preparation Market Regional share Analysis and Forecast, 2022–2025–2032

By Geography	2022	2025	2032
North America	39.00%	38.00%	35.00%
US	88.80%	88.50%	87.50%
Canada	11.20%	11.50%	12.50%
Europe	29.00%	28.70%	26.80%
Germany	22.50%	22.30%	21.50%
UK	15.20%	15.00%	14.50%
France	13.80%	13.60%	13.00%
Italy	9.50%	9.30%	8.80%
Spain	7.20%	7.40%	7.80%
Switzerland	8.00%	8.10%	8.50%
Netherlands	6.50%	6.70%	7.10%
Rest of Europe	17.30%	17.60%	18.80%
Asia Pacific	22.00%	23.30%	28.20%
China	31.00%	32.00%	34.00%
India	12.50%	13.80%	17.80%
Japan	26.50%	25.20%	22.00%
South Korea	7.50%	7.90%	8.80%
Australia	8.80%	8.40%	7.60%
Singapore	3.40%	3.40%	3.50%
Thailand	2.80%	3.00%	3.70%
Malaysia	2.60%	2.80%	3.40%
Indonesia	3.40%	3.90%	5.00%
Rest of Asia Pacific	2.00%	0.60%	0.20%
Middle East & Africa	4.00%	4.00%	4.00%
Saudi Arabia	22.00%	23.00%	26.00%
United Arab Emirates	15.80%	16.50%	19.00%
South Africa	28.00%	27.20%	25.00%
Israel	10.80%	11.00%	12.00%
Egypt	7.80%	8.20%	9.50%
Rest of MEA	15.60%	14.10%	8.50%
Latin America	6.00%	6.00%	6.00%
Brazil	44.50%	44.00%	42.50%
Mexico	22.00%	22.50%	24.00%
Argentina	10.00%	9.80%	9.00%
Chile	5.60%	5.80%	6.40%
Colombia	6.60%	6.90%	7.60%
Peru	4.20%	4.10%	4.30%
Rest of LA	7.10%	6.90%	6.20%

North America Blood Preparation Market Analysis:

North America Blood Preparation market held the largest share of 38.00% of the global market in 2025 and was valued at approximately USD 19.48 billion. The regional market is primarily driven by a well-established voluntary blood donation infrastructure, high healthcare expenditure, advanced plasma fractionation capacity, and strong regulatory oversight from the FDA covering blood and blood component manufacturing.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 North America Blood Preparation Market Size: USD 19.48 Billion
• 2035 North America Blood Preparation Market Size: USD 34.21 billion
• North America Blood Preparation Market CAGR (2026-2035): 6.40%

Drivers

• Well-established voluntary, non-remunerated blood donation system
• High healthcare expenditure and advanced trauma/surgical care infrastructure
• Strong domestic plasma fractionation and Source Plasma collection capacity
• Robust FDA regulatory and hemovigilance framework

Restraints

• Chronic and seasonal blood donor shortages
• High cost of component processing, testing and cold-chain logistics
• Stringent FDA donor eligibility and donation suitability requirements
• Workforce shortages of trained transfusion medicine professionals

Opportunities

• Expansion of apheresis-based component collection
• Growth in plasma-derived medicinal product manufacturing capacity

United States Blood Preparation Market Analysis

The U.S. accounted for the dominant share within North America and represented approximately 88.50% of the regional Blood Preparation market in 2025. The U.S. market was valued at nearly USD 17.24 billion, supported by an extensive network of blood establishments.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 US Blood Preparation Market Size: USD 17.24 Billion
• 2035 US Blood Preparation Market Size: USD 29.93 billion
• US Blood Preparation Market CAGR (2026-2035): 6.30%

Drivers

• Large-scale collection of blood components and Source Plasma for transfusion and fractionation
• High healthcare expenditure and broad insurance coverage for transfusion services
• FDA Office of Blood Research and Review oversight supporting quality and safety standards
• Continued FDA guidance updates (2024-2025) on donor eligibility and component manufacturing

Restraints

• High cost of advanced blood establishment infrastructure and consumables
• Stringent FDA donor eligibility, donation suitability and licensing requirements
• Reimbursement and cost-containment pressures across hospital systems
• Shortage of skilled transfusion medicine and blood-bank personnel

Opportunities

• Expansion of Source Plasma collection capacity for immunoglobulin and albumin production
• Adoption of buffy-coat and automated component-separation methods

Canada Blood Preparation Market Analysis

Canada represented approximately 11.50% of the North American Blood Preparation market in 2025 and was valued at around USD 2.24 billion. The market is supported by Canadian Blood Services and Hema-Québec, which coordinate nationally managed voluntary blood donation, component processing, and plasma collection programmers across the country.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Canada Blood Preparation Market Size: USD 2.24 Billion
• 2035 Canada Blood Preparation Market Size: USD 4.28 billion
• Canada Blood Preparation Market CAGR (2026-2035): 7.40%

Drivers

• Nationally coordinated blood donation system (Canadian Blood Services, Hema-Québec)
• Increasing government healthcare investment in transfusion medicine
• Growing domestic plasma collection initiatives to reduce import reliance
• Strong research collaboration with academic transfusion medicine institutions

Restraints

• Smaller donor base and market size relative to the U.S.
• Geographic challenges in serving remote and northern communities
• Regulatory alignment requirements with Health Canada biologics standards
• Periodic seasonal blood and platelet shortages

Opportunities

• Expansion of domestic plasma-for-fractionation programmers
• Increased apheresis donation capacity in major urban centers

Europe Blood Preparation Market Analysis

Europe accounted for approximately 28.70% of the global Blood Preparation market in 2025 and was valued at nearly USD 14.71 billion. The market benefits from harmonized technical standards under the EDQM Blood Guide and the new EU Regulation on Substances of Human Origin (EU) 2024/1938, which strengthens quality and safety requirements for blood, plasma and blood components across member states.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Europe Blood Preparation Market Size: USD 14.71 Billion
• 2035 Europe Blood Preparation Market Size: USD 26.79 billion
• Europe Blood Preparation Market CAGR (2026-2035): 6.10%

Drivers

• Harmonized EDQM Blood Guide technical standards (22nd edition, 2025)
• Implementation of EU SoHO Regulation (EU) 2024/1938 strengthening quality oversight
• Growing whole blood, platelet apheresis and plasma collection volumes (EDQM 2020-2023 activity data)
• Significant EU and Council of Europe funding for blood-sector modernization

Restraints

• Fragmented national implementation timelines ahead of full SoHO Regulation application in 2027
• Plasma supply gaps highlighted in the EDQM's 2026 plasma-supply report
• Economic constraints affecting blood-sector investment in parts of Eastern Europe
• Competition from North American and Asian plasma-derived product manufacturers

Opportunities

• EU-wide plasma self-sufficiency initiatives
• Adoption of updated EDQM hemovigilance and donor-selection standards

United Kingdom Blood Preparation Market Analysis

The UK represented approximately 15.00% of the European Blood Preparation market in 2025 and was valued at nearly USD 2.21 billion. NHS Blood and Transplant has collected over 250,000 liters of plasma from English donors since the 2021 lifting of the domestic plasma ban.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 UK Blood Preparation Market Size: USD 2.21 Billion
• 2035 UK Blood Preparation Market Size: USD 3.8 billion
• UK Blood Preparation Market CAGR (2026-2035): 6.10%

Drivers

• NHS Blood and Transplant domestic plasma collection and fractionation programmed
• Government 'Plan for Change' investment in plasma self-sufficiency
• Resumption of UK-sourced plasma medicines following MHRA safety review (2021)
• Established voluntary blood donation network across England, Scotland, Wales and Northern Ireland

Restraints

• Legacy vCJD-related restrictions shaping donor eligibility policy
• July 2024 national patient safety alert highlighting critically low blood stocks
• NHS budget constraints and reimbursement pressures
• Reliance on a limited number of plasma donor centers (Birmingham, Reading, Twickenham)

Opportunities

• Scaling immunoglobulin and albumin self-sufficiency toward 2031 targets
• Expansion of plasma donor center network across the UK

Germany Blood Preparation Market Analysis

Germany accounted for approximately 22.30% of the European Blood Preparation market in 2025 and was valued at around USD 3.28 billion. The country remains a key European hub for blood and plasma-derived product manufacturing, supported by the Paul-Ehrlich-Institute’s regulatory oversight and the German Red Cross Blood Donation Service network.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Germany Blood Preparation Market Size: USD 3.28 Billion
• 2035 Germany Blood Preparation Market Size: USD 5.63 billion
• Germany Blood Preparation Market CAGR (2026-2035): 6.00%

Drivers

• Strong domestic plasma collection and fractionation industry
• Paul-Ehrlich-Institute regulatory oversight of blood and biologics
• Extensive German Red Cross Blood Donation Service (DRK-Blutspendedienst) network
• Robust statutory health insurance system supporting transfusion services

Restraints

• High labor and operational costs for blood establishments
• Stringent data-protection and donor-eligibility regulations
• Declining donor base among younger demographics
• Aging population increasing transfusion demand and cost pressure

Opportunities

• Expansion of automated component-separation and digital donor management
• Continued growth in plasma-for-fractionation export capacity

France Blood Preparation Market Analysis

France represented approximately 13.60% of the European Blood Preparation market in 2025 and was valued at nearly USD 2 billion. The Establishment français du sang (EFS), as the sole national blood operator, coordinates voluntary blood collection, component processing and plasma supply across the country.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 France Blood Preparation Market Size: USD 2 Billion
• 2035 France Blood Preparation Market Size: USD 3.4 billion
• France Blood Preparation Market CAGR (2026-2035): 6.00%

Drivers

• Centralized national blood operator (EFS) ensures coordinated supply
• Strong public-health investment in transfusion safety
• Government support for plasma collection to reduce import dependence
• Established donor mobilization campaigns nationwide

Restraints

• Bureaucratic regulatory and procurement processes
• Periodic seasonal donor shortfalls, particularly in summer months
• Reimbursement variability across regional health authorities
• Competition from German and other European plasma-derived product suppliers

Opportunities

• Expansion of plasma collection capacity to support EU self-sufficiency goals
• Modernization of EFS regional collection and processing centers

Italy Blood Preparation Market Analysis

Italy accounted for approximately 9.30% of the European Blood Preparation market in 2025 and was valued at around USD 1.37 billion. The Centro Nazionale Sangu coordinates the national blood transfusion system and has formally adopted the EDQM's 22nd-edition Blood Guide as a technical reference for blood-component preparation and quality assurance.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Italy Blood Preparation Market Size: USD 1.37 Billion
• 2035 Italy Blood Preparation Market Size: USD 2.3 billion
• Italy Blood Preparation Market CAGR (2026-2035): 5.80%

Drivers

• National coordination via the Centro Nazionale Sangu
• Adoption of EDQM Blood Guide (22nd edition, 2025) as national technical reference
• Government healthcare investment in transfusion infrastructure
• Long-standing voluntary, non-remunerated donation culture

Restraints

• Regional disparities in blood-collection capacity across Italy
• Reimbursement and budget constraints in public healthcare
• Shortage of skilled transfusion-medicine professionals in some regions
• Regulatory compliance costs tied to EU SoHO Regulation transition

Opportunities

• Expansion of apheresis and plasma-for-fractionation programmers
• Digitalization of donor recruitment and inventory management

Spain Blood Preparation Market Analysis

Spain represented approximately 7.40% of the European Blood Preparation market in 2025 and was valued at nearly USD 1.09 billion. The Spanish Ministry of Health coordinates the national blood and tissue plan, supporting expanding clinical and public-health blood-component testing and processing capacity.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Spain Blood Preparation Market Size: USD 1.09 Billion
• 2035 Spain Blood Preparation Market Size: USD 1.04 billion
• Spain Blood Preparation Market CAGR (2026-2035): 6.50%

Drivers

• National blood and tissue plan coordinated by the Ministry of Health
• Expanding clinical PCR/serology-based donor screening capacity
• Government healthcare investment in regional transfusion centers
• Strong voluntary donation tradition across autonomous communities

Restraints

• High cost of advanced component-processing technologies
• Budget constraints in regional public healthcare systems
• Shortage of specialized laboratory and transfusion-medicine personnel
• Regulatory and compliance requirements under EU SoHO transition

Opportunities

• Growth of plasma-for-fractionation collection programmers
• Modernization of regional blood-bank infrastructure

Switzerland Blood Preparation Market Analysis

Switzerland accounted for approximately 8.10% of the European Blood Preparation market in 2025 and was valued at around USD 1.19 billion. Blasphemed SRK Schweiz (Swiss Red Cross Blood Transfusion Service) coordinates a decentralized national network of regional blood-collection centers known for high-quality, innovation-driven transfusion services.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Switzerland Blood Preparation Market Size: USD 1.19 Billion
• 2035 Switzerland Blood Preparation Market Size: USD 2.23 billion
• Switzerland Blood Preparation Market CAGR (2026-2035): 6.30%

Drivers

• Strong national blood-transfusion service network (Blasphemed SRK Schweiz)
• High adoption of advanced component-separation and testing technologies
• Robust biotechnology and pharmaceutical industry presence
• Strict national quality and safety standards

Restraints

• High cost of blood-establishment operations and assays
• Stringent Swissmedic regulatory requirements
• Limited access in smaller, rural healthcare facilities
• Skilled workforce shortages in specialized transfusion services

Opportunities

• Expansion of plasma collection for fractionation partnerships
• Increasing investment in donor-recruitment digital platforms

Netherlands Blood Preparation Market Analysis

The Netherlands represented approximately 6.70% of the European Blood Preparation market in 2025 and was valued at nearly USD 0.99 billion. Sanquin, the Dutch national blood supply foundation, manages the country's entire blood collection, component processing, and plasma-fractionation chain on a not-for-profit basis.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Netherlands Blood Preparation Market Size: USD 0.99 Billion
• 2035 Netherlands Blood Preparation Market Size: USD 1.86 billion
• Netherlands Blood Preparation Market CAGR (2026-2035): 6.40%

Drivers

• Integrated national blood-supply foundation (Sanquin) covering collection through fractionation
• Well-established public-health laboratory and hemovigilance networks
• Strong domestic plasma-fractionation manufacturing capability
• High public trust in voluntary, non-remunerated donation

Restraints

• High operating costs of an integrated not-for-profit blood system
• Donor-base demographic pressures amid an aging population
• Regulatory compliance costs under EU SoHO transition
• Dependence on consistent donor turnout to meet plasma targets

Opportunities

• Expansion of Sanquin's plasma-fractionation export capacity
• Continued innovation in component-separation technology

Asia Pacific Blood Preparation Market Analysis

Asia Pacific Blood Preparation market accounted for approximately 23.30% of the global market in 2025 and was valued at nearly USD 11.94 billion and is expected to register the fastest growth over the forecast period. Growth is driven by large patient populations, expanding voluntary blood donation programmers, and rising government investment in transfusion-service infrastructure across China, India, Japan and Southeast Asia.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Asia Pacific Blood Preparation Market Size: USD 11.94 Billion
• 2035 Asia Pacific Blood Preparation Market Size: USD 27.56 billion
• Asia Pacific Blood Preparation Market CAGR (2026-2035): 8.20%

Drivers

• Large and growing patient population requiring transfusion support
• Expanding national voluntary blood donation programmers
• Rising government investment in blood-bank digitalization
• Growing domestic plasma-fractionation capacity in China and India

Restraints

• Wide disparities in blood-collection rates between high- and low-income countries in the region
• Shortage of trained transfusion-medicine professionals in parts of Southeast Asia
• Cold-chain and logistics constraints in rural and remote areas
• Regulatory heterogeneity across national health authorities

Opportunities

• Expansion of apheresis and component-separation infrastructure
• Government-backed digitalization of donor and inventory management systems

China Blood Preparation Market Analysis

China represented approximately 32.00% of the Asia Pacific Blood Preparation market in 2025 and was valued at around USD 3.82 billion. The National Health Commission continues to expand the country's voluntary, unpaid blood-donation system and regulate plasma-collection stations under the Regulations on the Administration of Blood Donation.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 China Blood Preparation Market Size: USD 3.82 Billion
• 2035 China Blood Preparation Market Size: USD 9.37 billion
• China Blood Preparation Market CAGR (2026-2035): 8.80%

Drivers

• National Health Commission-led expansion of voluntary blood donation
• Growing network of licensed plasma-collection stations for fractionation
• Rising hospital and trauma-care infrastructure investment
• Government support for domestic plasma-derived medicinal product manufacturing

Restraints

• Regional disparities in blood-collection rates between urban and rural areas
• Strict regulatory licensing requirements for plasma-collection stations
• Periodic seasonal and regional blood shortages
• Rising operational costs for component testing and processing

Opportunities

• Expansion of domestic plasma-fractionation capacity
• Adoption of nucleic acid testing (NAT) and automated component separation

India Blood Preparation Market Analysis

India accounted for approximately 13.80% of the Asia Pacific Blood Preparation market in 2025 and was valued at nearly USD 1.65 billion. The Ministry of Health and Family Welfare's e-RaktKosh platform and National Blood Transfusion Council coordinate blood-center registration, real-time inventory tracking, and quality-assurance programmers across thousands of blood banks nationwide.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 India Blood Preparation Market Size: USD 1.65 Billion
• 2035 India Blood Preparation Market Size: USD 4.91 billion
• India Blood Preparation Market CAGR (2026-2035): 10.20%

Drivers

• e-RaktKosh centralized digital blood-bank management platform
• National Blood Transfusion Council-led voluntary donation drives
• WHO India collaboration on National External Quality Assurance Scheme implementation
• Expanding Indian Red Cross Society and state blood-transfusion-council networks

Restraints

• Continued reliance on replacement/family donors in some states
• Shortage of trained blood-bank technicians in rural regions
• Infrastructure and cold-chain gaps in remote areas
• Regulatory compliance burden under CDSCO blood-bank licensing norms

Opportunities

• Scaling voluntary donation culture nationwide
• Expansion of NAT-based testing and component-separation capacity

Japan Blood Preparation Market Analysis

Japan represented approximately 25.20% of the Asia Pacific Blood Preparation market in 2025 and was valued at around USD 3.01 billion. The Japanese Red Cross Society operates the country's entire blood-donation and component-processing system under Ministry of Health, Labor and Welfare oversight.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Japan Blood Preparation Market Size: USD 3.01 Billion
• 2035 Japan Blood Preparation Market Size: USD 6.06 billion
• Japan Blood Preparation Market CAGR (2026-2035): 5.50%

Drivers

• Centralized Japanese Red Cross Society blood-supply system
• High public trust in voluntary, non-remunerated donation
• Advanced automated component-processing and testing technology
• Strong regulatory oversight from MHLW and PMDA

Restraints

• Aging donor population and declining birth rate reducing donor pool
• High cost of advanced screening and processing technology
• Limited domestic plasma-fractionation capacity relative to demand
• Regional logistics challenges in maintaining cold-chain distribution

Opportunities

• Donor-recruitment campaigns targeting younger demographics
• Expansion of domestic plasma-derived product manufacturing

South Korea Blood Preparation Market Analysis

South Korea accounted for approximately 7.90% of the Asia Pacific Blood Preparation market in 2025 and was valued at nearly USD 0.94 billion. The Korean Red Cross Blood Services manages national blood collection, testing and component-processing operations under Ministry of Health and Welfare regulation.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 South Korea Blood Preparation Market Size: USD 0.94 Billion
• 2035 South Korea Blood Preparation Market Size: USD 2.43 billion
• South Korea Blood Preparation Market CAGR (2026-2035): 8.10%

Drivers

• Centralized Korean Red Cross blood-supply network
• High adoption of automated and NAT-based testing technology
• Strong government healthcare investment
• Advanced hospital infrastructure supporting transfusion services

Restraints

• Declining donor base among younger population segments
• High cost of advanced laboratory and processing equipment
• Regulatory compliance requirements under Ministry of Food and Drug Safety oversight
• Seasonal blood-shortage challenges

Opportunities

• Digital donor-engagement and mobile donation initiatives
• Expansion of plasma-for-fractionation collection

Singapore Blood Preparation Market Analysis

Singapore represented approximately 3.40% of the Asia Pacific Blood Preparation market in 2025 and was valued at around USD 0.41 billion. The Health Sciences Authority's Blood Services Group manages the national blood supply, supported by strong regulatory oversight and advanced clinical infrastructure.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Singapore Blood Preparation Market Size: USD 0.41 Billion
• 2035 Singapore Blood Preparation Market Size: USD 0.96 billion
• Singapore Blood Preparation Market CAGR (2026-2035): 6.60%

Drivers

• Centralized national Blood Services Group under HSA oversight
• Advanced hospital and laboratory infrastructure
• High public trust in voluntary blood donation
• Strong regional hub status for clinical and research collaboration

Restraints

• Small domestic donor population relative to demand
• High operating costs for advanced testing technology
• Reliance on regular donor mobilization campaigns to offset shortages
• Limited domestic plasma-fractionation capacity

Opportunities

• Expansion of regional blood-research and biobanking initiatives
• Adoption of advanced apheresis collection technology

Australia Blood Preparation Market Analysis

Australia accounted for approximately 8.40% of the Asia Pacific Blood Preparation market in 2025 and was valued at nearly USD 1 billion. Australian Red Cross Lifeblood manages the national blood and plasma supply, regulated by the Therapeutic Goods Administration.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Australia Blood Preparation Market Size: USD 1 Billion
• 2035 Australia Blood Preparation Market Size: USD 2.09 billion
• Australia Blood Preparation Market CAGR (2026-2035): 5.90%

Drivers

• Centralized Lifeblood national blood and plasma collection network
• Strong government healthcare investment in transfusion services
• Growing domestic plasma-collection programmed to support fractionation
• Advanced TGA regulatory and quality-assurance framework

Restraints

• Geographic challenges in serving remote and regional communities
• High cost of component processing and cold-chain logistics
• Donor-based demographic pressures
• Reliance on imported plasma-derived medicinal products for some products

Opportunities

• Expansion of plasma-collection capacity toward national self-sufficiency
• Investment in mobile and community-based donation centers

Thailand Blood Preparation Market Analysis

Thailand represented approximately 3.00% of the Asia Pacific Blood Preparation market in 2025 and was valued at around USD 0.36 billion. The National Blood Centre, Thai Red Cross Society, coordinates blood collection and component processing nationwide, supported by Ministry of Public Health regulation.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Thailand Blood Preparation Market Size: USD 0.36 Billion
• 2035 Thailand Blood Preparation Market Size: USD 1.02 billion
• Thailand Blood Preparation Market CAGR (2026-2035): 8.20%

Drivers

• National Blood Centre-led coordinated collection network
• Government healthcare investment in regional blood-bank infrastructure
• Growing voluntary donation participation
• Expanding hospital and trauma-care capacity

Restraints

• Shortage of skilled transfusion-medicine technicians in provincial areas
• Cold-chain and logistics constraints outside major cities
• Budget constraints in public-sector blood-bank funding
• Seasonal donor shortfalls

Opportunities

• Expansion of regional blood-bank modernization programmers
• Growth in plasma-component processing capacity

Malaysia Blood Preparation Market Analysis

Malaysia accounted for approximately 2.80% of the Asia Pacific Blood Preparation market in 2025 and was valued at nearly USD 0.33 billion. The National Blood Centre (Pusat Darah Negara) under the Ministry of Health coordinates national blood collection, processing and distribution.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Malaysia Blood Preparation Market Size: USD 0.33 Billion
• 2035 Malaysia Blood Preparation Market Size: USD 0.94 billion
• Malaysia Blood Preparation Market CAGR (2026-2035): 8.10%

Drivers

• Centralized National Blood Centre under Ministry of Health oversight
• Government investment in regional blood-bank infrastructure
• Growing voluntary, non-remunerated donation participation
• Expanding hospital transfusion-service capacity

Restraints

• Donor shortages relative to growing clinical demand
• Logistics challenges in East Malaysia and rural areas
• Shortage of specialized transfusion-medicine personnel
• Budget constraints in public healthcare funding

Opportunities

• Expansion of mobile and community donation drives
• Modernization of component-processing technology

Indonesia Blood Preparation Market Analysis

Indonesia accounted for approximately 3.90% of the Asia Pacific Blood Preparation market in 2025 and was valued at nearly USD 0.47 billion. Paling Merah Indonesia (Indonesian Red Cross) coordinates the majority of national blood collection under Ministry of Health regulation.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Indonesia Blood Preparation Market Size: USD 0.47 Billion
• 2035 Indonesia Blood Preparation Market Size: USD 1.38 billion
• Indonesia Blood Preparation Market CAGR (2026-2035): 9.10%

Drivers

• PMI-led nationwide voluntary blood-collection network
• Ministry of Health investment in regional blood-bank infrastructure
• Large and growing population driving clinical transfusion demand
• Expanding hospital and emergency-care capacity

Restraints

• Significant disparities in blood-collection rates across provinces
• Logistics and cold-chain challenges across the archipelago
• Shortage of trained transfusion-medicine personnel
• Budget constraints in public-sector blood-bank funding

Opportunities

• Expansion of regional blood-bank modernization programmers
• Growth in component-processing and testing capacity

Middle East & Africa Blood Preparation Market Analysis

Middle East & Africa Blood Preparation market accounted for approximately 4.00% of the global market in 2025 and was valued at nearly USD 2.05 billion. Growth is supported by government healthcare investment, expanding national blood-transfusion services, and rising trauma- and surgery-related transfusion demand across the GCC and broader Africa region.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Middle East & Africa Blood Preparation Market Size: USD 2.05 Billion
• 2035 Middle East & Africa Blood Preparation Market Size: USD 3.91 billion
• Middle East & Africa Blood Preparation Market CAGR (2026-2035): 7.30%

Drivers

• Government healthcare investment in national blood-transfusion services
• Expanding voluntary blood-donation campaigns across the GCC
• Growing hospital and trauma-care infrastructure
• Rising regional collaboration on hemovigilance standards

Restraints

• Wide disparities in blood-safety infrastructure between GCC and lower-income African countries
• Shortage of trained transfusion-medicine professionals in parts of Africa
• Logistics and cold-chain constraints in remote regions
• Limited domestic plasma-fractionation capacity

Opportunities

• Expansion of national blood-transfusion modernization programmers
• Growing regional investment in component-separation technology

Saudi Arabia Blood Preparation Market Analysis

Saudi Arabia represented approximately 23.00% of the Middle East & Africa Blood Preparation market in 2025 and was valued at around USD 0.47 billion. The Ministry of Health coordinates national blood-donation centers and transfusion-service standards under its Vision 2030 healthcare transformation programmed.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Saudi Arabia Blood Preparation Market Size: USD 0.47 Billion
• 2035 Saudi Arabia Blood Preparation Market Size: USD 1.02 billion
• Saudi Arabia Blood Preparation Market CAGR (2026-2035): 8.80%

Drivers

• Ministry of Health-led national Blood Donation center network
• Vision 2030 healthcare transformation investment in transfusion services
• Growing hospital and trauma-care infrastructure
• Expanding voluntary donation awareness campaigns

Restraints

• High dependence on periodic donation campaigns to meet demand
• Shortage of specialized transfusion-medicine personnel
• High cost of advanced component-processing technology
• Regulatory compliance requirements under Saudi FDA oversight

Opportunities

• Expansion of regional blood-bank modernization under Vision 2030
• Growth in automated component-separation capacity

United Arab Emirates Blood Preparation Market Analysis

The UAE accounted for approximately 16.50% of the Middle East & Africa Blood Preparation market in 2025 and was valued at nearly USD 0.34 billion. The Ministry of Health and Prevention and Dubai Health Authority coordinate national and emirate-level blood-donation and transfusion services.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 UAE Blood Preparation Market Size: USD 0.34 Billion
• 2035 UAE Blood Preparation Market Size: USD 0.74 billion
• UAE Blood Preparation Market CAGR (2026-2035): 8.90%

Drivers

• Coordinated national and emirate-level blood-donation programmed
• Government investment in advanced hospital transfusion infrastructure
• Growing medical-tourism-driven demand for transfusion services
• Expanding voluntary donation awareness campaigns

Restraints

• Small domestic donor population relative to expatriate-driven demand
• High cost of advanced testing and component-processing technology
• Reliance on periodic blood-drive campaigns
• Limited domestic plasma-fractionation capacity

Opportunities

• Expansion of regional blood-bank modernization
• Growth in apheresis-based component collection

South Africa Blood Preparation Market Analysis

South Africa represented approximately 27.20% of the Middle East & Africa Blood Preparation market in 2025 and was valued at around USD 0.56 billion. The South African National Blood Service (SANBS) and Western Cape Blood Service coordinate voluntary blood collection and component processing nationwide.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 South Africa Blood Preparation Market Size: USD 0.56 Billion
• 2035 South Africa Blood Preparation Market Size: USD 0.98 billion
• South Africa Blood Preparation Market CAGR (2026-2035): 6.10%

Drivers

• Established national blood-service network (SANBS, WCBS)
• Government healthcare investment in transfusion-service infrastructure
• Growing voluntary, non-remunerated donation participation
• Strong hemovigilance and donor-screening systems

Restraints

• Persistent blood shortages relative to population health needs
• High prevalence of transfusion-transmissible infections requiring extensive screening
• Logistics and cold-chain constraints in rural provinces
• Budget constraints in public-sector healthcare funding

Opportunities

• Expansion of mobile and community-based donation drives
• Investment in advanced NAT-based screening technology

Egypt Blood Preparation Market Analysis

Egypt accounted for approximately 8.20% of the Middle East & Africa Blood Preparation market in 2025 and was valued at nearly USD 0.17 billion. The Ministry of Health and Population's National Blood Transfusion Services coordinates blood-bank regulation and donor-screening standards nationwide.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Egypt Blood Preparation Market Size: USD 0.17 Billion
• 2035 Egypt Blood Preparation Market Size: USD 0.37 billion
• Egypt Blood Preparation Market CAGR (2026-2035): 8.20%

Drivers

• Ministry of Health-led national blood-transfusion services
• Growing government healthcare investment in transfusion infrastructure
• Expanding voluntary donation awareness campaigns
• Raising hospital and trauma-care capacity

Restraints

• Persistent blood shortages relative to population needs
• Shortage of trained transfusion-medicine personnel
• Logistics and cold-chain constraints outside major cities
• Budget constraints in public-sector healthcare funding

Opportunities

• Expansion of regional blood-bank modernization programmers
• Growth in component-separation and testing capacity

Israel Blood Preparation Market Analysis

Israel represented approximately 11.00% of the Middle East & Africa Blood Preparation market in 2025 and was valued at around USD 0.23 billion. Magen David Adom's National Blood Services Centre manages the country's entire blood-collection, processing and distribution chain.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Israel Blood Preparation Market Size: USD 0.23 Billion
• 2035 Israel Blood Preparation Market Size: USD 0.47 billion
• Israel Blood Preparation Market CAGR (2026-2035): 7.60%

Drivers

• Centralized Magen David Adom National Blood Services Centre
• Advanced automated component-processing and testing technology
• Strong government healthcare investment
• High public participation in voluntary donation, including emergency mobilization

Restraints

• Periodic surges in clinical demand during regional emergencies
• High cost of advanced laboratory and processing infrastructure
• Shortage of specialized transfusion-medicine personnel
• Regulatory compliance requirements under Ministry of Health oversight

Opportunities

• Expansion of plasma-collection and processing capacity
• Investment in mobile and rapid-response donation units

Latin America Blood Preparation Market Analysis

Latin America Blood Preparation market accounted for approximately 6.00% of the global market in 2025 and was valued at nearly USD 3.08 billion. The Pan American Health Organization (PAHO/WHO) supports the region's nationally coordinated blood-transfusion programmers, with blood-collection volumes across Latin America and the Caribbean continuing to expand year-on-year.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Latin America Blood Preparation Market Size: USD 3.08 Billion
• 2035 Latin America l Blood Preparation Market Size: USD 5.86 billion
• Latin America Blood Preparation Market CAGR (2026-2035): 6.90%

Drivers

• PAHO/WHO-supported expansion of nationally coordinated blood programmers
• Growing voluntary, non-remunerated donation participation
• Government healthcare investment in regional blood-bank infrastructure
• Rising hospital and trauma-care demand

Restraints

• Disparities in blood-collection rates between urban and rural areas
• Shortage of trained transfusion-medicine professionals in several countries
• Logistics and cold-chain constraints in remote regions
• Budget constraints in public-sector healthcare funding

Opportunities

• Expansion of regional blood-bank modernization programmers
• Growth in component-separation and NAT-based testing capacity

Brazil Blood Preparation Market Analysis

Brazil represented approximately 44.00% of the Latin America Blood Preparation market in 2025 and was valued at around USD 1.36 billion. The Ministry of Health's national blood-transfusion network (Hembree) and Hembras coordinate collection, processing and domestic plasma-fractionation capacity.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Brazil Blood Preparation Market Size: USD 1.36 Billion
• 2035 Brazil Blood Preparation Market Size: USD 2.46 billion
• Brazil Blood Preparation Market CAGR (2026-2035): 6.80%

Drivers

• National blood-transfusion network (Hemorrede) coordinated by the Ministry of Health
• Domestic plasma-fractionation capability through Hembras
• Growing voluntary donation participation
• Expanding hospital and trauma-care infrastructure

Restraints

• Regional disparities in blood-collection capacity across states
• Shortage of trained transfusion-medicine personnel in some regions
• Logistics and cold-chain constraints in remote areas of the Amazon basin
• Budget constraints in public-sector healthcare funding

Opportunities

• Expansion of Hembras domestic plasma-fractionation capacity
• Growth in NAT-based testing and automated component processing

Mexico Blood Preparation Market Analysis

Mexico accounted for approximately 22.50% of the Latin America Blood Preparation market in 2025 and was valued at nearly USD 0.69 billion. The Centro Nacional de la Transfusion Sanguinei coordinates national blood-policy, donor-screening standards and component-processing regulation.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Mexico Blood Preparation Market Size: USD 0.69 Billion
• 2035 Mexico Blood Preparation Market Size: USD 1.41 billion
• Mexico Blood Preparation Market CAGR (2026-2035): 7.30%

Drivers

• National coordination via the Centro Nacional de la Transfusion Sanguinei
• Government healthcare investment in transfusion infrastructure
• Growing voluntary donation participation
• Expanding hospital and trauma-care capacity

Restraints

• Continued reliance on family/replacement donors in parts of the country
• Shortage of trained transfusion-medicine personnel
• Logistics and cold-chain constraints in rural states
• Budget constraints in public healthcare funding

Opportunities

• Expansion of voluntary-donation promotion programmers
• Growth in component-separation and testing capacity

Argentina Blood Preparation Market Analysis

Argentina represented approximately 9.80% of the Latin America Blood Preparation market in 2025 and was valued at around USD 0.3 billion. The Ministry of Health's National Blood Plan coordinates blood-bank regulation, donor-screening standards and hemovigilance across the country's provinces.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Argentina Blood Preparation Market Size: USD 0.3 Billion
• 2035 Argentina Blood Preparation Market Size: USD 0.56 billion
• Argentina Blood Preparation Market CAGR (2026-2035): 6.20%

Drivers

• National Blood Plan coordinated by the Ministry of Health
• Growing voluntary, non-remunerated donation participation
• Government investment in regional blood-bank infrastructure
• Expanding hospital and trauma-care demand

Restraints

• Regional disparities in blood-collection capacity across provinces
• Economic constraints affecting public healthcare investment
• Shortage of trained transfusion-medicine personnel
• Logistics challenges in remote provinces

Opportunities

• Expansion of voluntary donation awareness campaigns
• Growth in component-processing modernization

Chile Blood Preparation Market Analysis

Chile accounted for approximately 5.80% of the Latin America Blood Preparation market in 2025 and was valued at nearly USD 0.18 billion. The Monasterio de Salud coordinates the national blood-bank network and donor-screening standards across regional health services.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Chile Blood Preparation Market Size: USD 0.18 Billion
• 2035 Chile Blood Preparation Market Size: USD 0.38 billion
• Mexico Chile Preparation Market CAGR (2026-2035): 7.40%

Drivers

• Ministry of Health-coordinated national blood-bank network
• Growing voluntary donation participation
• Government investment in regional health-service infrastructure
• Expanding hospital and trauma-care capacity

Restraints

• Donor shortages relative to growing clinical demand
• Shortage of trained transfusion-medicine personnel
• Logistics challenges in southern and remote regions
• Budget constraints in public healthcare funding

Opportunities

• Expansion of voluntary-donation promotion programmers
• Growth in component-separation and testing capacity

Colombia Blood Preparation Market Analysis

Colombia represented approximately 6.90% of the Latin America Blood Preparation market in 2025 and was valued at around USD 0.21 billion. The Instituto Nacional de Salud coordinates the Red Nacional de Bancos de Sangre, overseeing blood-bank regulation and donor-screening standards nationwide.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Colombia Blood Preparation Market Size: USD 0.21 Billion
• 2035 Colombia Blood Preparation Market Size: USD 0.45 billion
• Colombia Blood Preparation Market CAGR (2026-2035): 7.30%

Drivers

• National coordination via the Red Nacional de Bancos de Sangre
• Government healthcare investment in transfusion infrastructure
• Growing voluntary donation participation
• Expanding hospital and trauma-care demand

Restraints

• Regional disparities in blood-collection capacity
• Shortage of trained transfusion-medicine personnel
• Logistics and security-related constraints in some regions
• Budget constraints in public-sector healthcare funding

Opportunities

• Expansion of regional blood-bank modernization programmers
• Growth in component-processing and testing capacity

Peru Blood Preparation Market Analysis

Peru accounted for approximately 4.10% of the Latin America Blood Preparation market in 2025 and was valued at nearly USD 0.13 billion. The Monasterio de Salud's National Haemotherapy and Blood Bank Program coordinates donor-screening, component-processing and distribution standards nationwide.

Market Intelligence Overview (Historical, Current, Forecast):

• 2025 Peru Blood Preparation Market Size: USD 0.13 Billion
• 2035 Peru Blood Preparation Market Size: USD 0.25 billion
• Peru Blood Preparation Market CAGR (2026-2035): 6.70%

Drivers

• National Chemotherapy and Blood Bank Program coordinated by the Ministry of Health
• Growing voluntary donation participation
• Government investment in regional healthcare infrastructure
• Expanding hospital and trauma-care capacity

Restraints

• Continued reliance on family/replacement donors in parts of the country
• Shortage of trained transfusion-medicine personnel
• Logistics and cold-chain constraints in Andean and Amazonian regions
• Budget constraints in public healthcare funding

Opportunities

• Growth in component-separation and testing capacity
• Expansion of voluntary-donation promotion programmers

Blood Preparation Market Key Players:

• CSL Limited
• Grifols, S.A.
• Fresenius Kabi AG
• Octapharma AG
• Haemonetics Corporation
• Others
• Becton, Dickinson and Company
• Immucor, Inc
• Baxter International
• Terumo Corporation
• B. Braun
• Takeda Pharmaceutical Company
• Kedrion Biopharma
• LFB
• Biotest

Blood Preparation Market Recent Developments

• FDA Issued Updated Guidance for Blood Collection, Processing, and Storage Systems (2026): In April 2026, the U.S. Food and Drug Administration (FDA) published updated guidance concerning the development of blood collection, processing, and storage systems used in the manufacture of blood components. The guidance aims to improve blood component quality, safety, and standardization while supporting innovation in blood preparation technologies.
• FDA Recognized the June 2024 Circular of Information for Blood Components: The FDA formally recognized the June 2024 Circular of Information for the Use of Human Blood and Blood Components as an extension of product labeling. The document provides updated instructions regarding the preparation, storage, administration, and handling of blood components, enhancing safety and regulatory compliance across blood establishments.
• Council of Europe Released the 22nd Edition of Blood Component Quality Guidelines (2025): The European Directorate for the Quality of Medicines & HealthCare (EDQM) published the 22nd edition of its Guide to the Preparation, Use and Quality Assurance of Blood Components. The revised guide introduced enhanced hemovigilance standards, emergency blood supply planning, and new recommendations for topical blood components, supporting quality management across European blood centers.
• WHO Published the Global Status Report on Blood Safety and Availability (2025): The World Health Organization (WHO) released its Global Status Report on Blood Safety and Availability 2025, highlighting the need for improved blood processing capabilities, quality-assurance systems, and wider access to safe blood products. The report emphasizes strengthening national blood preparation infrastructure and promoting voluntary blood donation worldwide.
• India Strengthened Quality Assurance Programs for Blood Centers (2024–2025): India's Ministry of Health and Family Welfare, through the National Blood Transfusion Council (NBTC), expanded External Quality Assurance Scheme (EQAS) programs and promoted updated standards for blood centers and transfusion services. These initiatives focus on improving blood component preparation, screening, and quality control across the country.

Blood Preparation Market Regulatory Landscape Analysis

• FDA / EMA / PMDA / NMPA approvals and regulatory frameworks for blood collection, processing, storage, and transfusion products
• Accelerated approval pathways and emergency-use regulatory provisions for innovative blood preparation technologies and pathogen reduction systems
• Compliance framework overview, including GMP, cGMP, ISO 13485, AABB standards, EDQM guidelines, and hemovigilance requirements
• Regulatory impact assessment covering blood safety regulations, donor screening standards, traceability requirements, and post-market surveillance policies

Blood Preparation Market Patent & IP Landscape

• Patent expiry analysis for blood separation devices, leukoreduction filters, pathogen reduction technologies, and blood storage solutions
• IP competitiveness assessment among leading blood processing equipment manufacturers and transfusion medicine companies
• Licensing agreements, strategic collaborations, and technology-transfer partnerships for advanced blood preparation and preservation technologies
• Innovation clusters focusing on automated blood processing systems, AI-enabled blood analysis, pathogen inactivation technologies, and laboratory-grown blood products

Blood Preparation Market Segmentations:

Our research framework strategically segments the large molecule bioanalytical testing services market by testing methodologies, modality landscape, end-user categories, and key regional markets

By Product Type

• Whole Blood
• Red Blood Cells (RBCs)
• Platelets
• Plasma
• Cryoprecipitate
• Granulocytes
• Blood Derivatives

By Application

• Blood Transfusion
• Trauma and Emergency Care
• Surgical Procedures
• Oncology Treatment
• Haematological Disorders
• Cardiovascular Diseases
• Organ Transplantation
• Others

By End User

• Hospitals
• Blood Banks
• Diagnostic Laboratories
• Ambulatory Surgical Centres
• Specialty Clinics
• Research and Academic Institutes

By Region & Country

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Thailand
• Malaysia
• Philippines
• Rest of Asia-Pacific

Latin America

• Brazil
• Argentina
• Chile
• Rest of Latin America

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East & Africa

Key Report Attributes	Details
Years Considered	2022 to 2035
Market Size 2025	USD 51.25 Billion
Market Size 2035	USD 97.73 Billion
Historical CAGR % (Growth rate)	6.14% from 2022 to 2025
Futuristic CAGR % (Growth rate)	6.67% from 2026 to 2035
Segments Covered	By Type By Disease By Application By End-Use
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Switzerland, Netherlands, Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Singapore; Australia; Australia; Philippines; Indonesia; Brazil; Argentina; Indonesia; Chile; Colombia; Peru; South Africa; Egypt; Israel; Saudi Arabia; UAE; Kuwait
Competitive Landscape Overview	Merck KGaA Codexis, Inc. F. Hoffmann-La Roche Ltd. Amano Enzyme Inc. Advanced Enzymes Technologies Ltd. Biocatalysts Ltd. Amicogen Dyadic International BBI Solutions Affymetrix American Laboratories
Flexible Report Customization	The study can be customized based on geography, segment analysis, company profiling, competitive benchmarking, and strategic insights.
Data Sources	Primary and secondary sources used (Company filings, trade associations, Journals, Annual report, Publications, Surveys, Investor Presentations, and much more.